grant

Center for Studies of Host Response to Cancer Therapy

Organization UNIV OF ARKANSAS FOR MED SCISLocation LITTLE ROCK, UNITED STATESPosted 24 Jun 2015Deadline 31 May 2026
NIHUS FederalResearch GrantFY2024AddressAdverse effectsAdvisory CommitteesAffectAfter CareAfter-TreatmentAftercareAnimalsApplications GrantsArkansasAwardBiologicalBiomedical ResearchBody TissuesCOBRECancer DetectionCancer PatientCancer SurvivorCancer SurvivorshipCancer TreatmentCancersCenter of Biomedical Research ExcellenceCenters of Research ExcellenceChemotherapy and RadiationChemotherapy and/or radiationChildren's HospitalChronicClinicalCollaborationsDedicationsDevelopmentDevelopment PlansDisciplineDose LimitingEXTMREarly DiagnosisEnsureEnvironmentExtramuralExtramural ActivitiesFacultyFaculty EducationFaculty TrainingFee-for-Service PlansFees for ServiceFundingFunding AgencyFunding SourceGoalsGrant ProposalsIatrogenic CancerImmune responseImmune systemImmunological responseIndividualInstitutionInterdisciplinary ResearchInterdisciplinary StudyInvestigatorsLifeMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMedicalMentorsMethodsMultidisciplinary CollaborationMultidisciplinary ResearchNational Institutes of HealthOncologyOncology CancerPediatric HospitalsPhasePilot ProjectsPredispositionPreparationProcessProductivityQOLQualifyingQuality of lifeR-Series Research ProjectsR01 MechanismR01 ProgramRadiationRadiation therapyRadiotherapeuticsRadiotherapyResearchResearch GrantsResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch ProjectsResearch ResourcesResearch SupportResearchersResourcesRoleScienceScientistSecureServicesStructureSusceptibilityTask ForcesTeacher EducationTeacher EducatorTeacher PreparationTeacher Professional DevelopmentTeacher TrainingTherapeuticTherapy Related Malignant NeoplasmTherapy Related Malignant TumorTherapy-Associated CancersTherapy-Related CancerTissuesToxicologyTranslational ResearchTranslational ScienceTreatment EfficacyTreatment outcomeTreatment-Associated CancerTreatment-Related CancerTreatment-related toxicityUnited States National Institutes of HealthUniversitiesadvisory teamanti-cancer therapyanti-cancer treatmentbasebasesbiologiccancer therapycancer-directed therapycareerchemo/radiation therapychemotherapychemotherapy and radiotherapycomparativedevelopmentaldisabilityearly detectioneffective interventionfaculty developmentfaculty professional developmenthost responseimmune system responseimmunoresponseimprovedinstructor traininginterestintervention efficacymalignancymultidisciplinaryneoplasm/cancernew approachesnovel approachesnovel strategiesnovel strategypilot studypost treatmentpreparationspreventpreventingprogramspsychosocialquality of life and care for cancer survivorsquality of life for cancer survivorsradiation or chemotherapyradiation treatmentrecruitresponseside effectsocial rolesuccesssynergismteacher developmenttherapeutic efficacytherapeutic toxicitytherapy adverse effecttherapy associated toxicitytherapy efficacytherapy related toxicitytherapy toxicitytranslation researchtranslation strategytranslational approachtranslational investigationtranslational strategytreatment adverse effecttreatment toxicitytreatment with radiationtreatment-associated toxicitytumor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY/ABSTRACT
The objectives of the Center for Studies of Host Response to Cancer Therapy are to (1) form a self-sustaining

multidisciplinary research center within the University of Arkansas for Medical Sciences (UAMS) to increase the

understanding of mechanisms of side effects of cancer therapy, identify methods for early detection, and develop

strategies to prevent or treat such side effects and (2) help junior investigators with research programs in this

common theme establish themselves as independent scientists. Achieving these goals will create a vibrant,

multidisciplinary yet synergistic research environment. To our knowledge, few research centers focus on cancer

survivorship, and none take the paradigm-shifting approach of proactively addressing treatment-related toxicities

to improve overall cancer treatment outcomes. Specifically, this Center will provide an environment for young

investigators to succeed as independent scientists (Aim 1); strengthen the overall research infrastructure at

UAMS and the Winthrop P. Rockefeller Cancer Institute (Aim 2); and ensure that the Center becomes self-

sustaining (Aim 3). All 6 project leaders recruited to the Center in Phase 1 have built well-funded, productive

research programs and close collaborations with each other and several of the pilot project grantees. In

preparation for Phase 2, we have recruited 4 promising new/early-stage independent investigators. During Phase

1, the Center focused heavily on radiation therapy. To increase the impact and scope of the Center while

retaining its overall theme, project leaders recruited for Phase 2 have a research focus on both radiation and

chemotherapy. To increase the likelihood that project leaders will successfully secure independent extramural

research funding, individualized mentoring and faculty-development plans will be implemented, and support from

an administrative core and 2 research service cores will be integral. To replace project leaders who achieve

independence and graduate from COBRE support, a pipeline of new project leaders is ensured through

institutional support for recruiting junior faculty combined with a structured pilot project program. Strengthening

our interactions with the 5 other COBRE Centers and additional NIH-supported programs that enhance

biomedical research on the UAMS and affiliated campuses will also contribute to establishing the Center as a

self-sustaining research program that is well-integrated in the institution. The Center's progress will be guided

by highly qualified External and Internal Advisory Committees. Strong institutional support combined with active

interest from funding agencies in improving uncomplicated cancer cure rates and the quality of life of cancer

survivors ensures a high likelihood of success for the Center for Studies of Host Response to Cancer Therapy.

Grant Number: 5P20GM109005-10
NIH Institute/Center: NIH

Principal Investigator: Marjan Boerma

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →